Why screening rates vary between Korea and Japan-Differences between two national healthcare systems

Rei Goto, Chisato Hamashima, Sunghyun Mun, Won Chul Lee

Research output: Contribution to journalShort survey

6 Citations (Scopus)

Abstract

Both Japan and Korea provide population-based screening programs. However, screening rates are much higher in Korea than in Japan. To clarify the possible factors explaining the differences between these two countries, we analyzed the current status of the cancer screening and background healthcare systems. Populationbased cancer screening in Korea is coordinated well with social health insurance under a unified insurer system. In Japan, there are over 3,000 insurers and coordinating a comprehensive strategy for cancer screening promotion has been very difficult. The public healthcare system also has influence over cancer screening. In Korea, public healthcare does not cover a wide range of services. Almost free cancer screening and subsidization for medical cost for cancers detected in population-screening provides high incentive to participation. In Japan, on the other hand, a larger coverage of medical services, low co-payment, and a lenient medical audit enables people to have cancer screening under public health insurance as well as the broad range of cancer screening. The implementation of evidence-based cancer screening programs may be largely dependent on the background healthcare system. It is important to understand the impacts of each healthcare system as a whole and to match the characteristics of a particular health system when designing an efficient cancer screening system.

Original languageEnglish
Pages (from-to)395-400
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume16
Issue number2
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Korea
Early Detection of Cancer
Japan
Delivery of Health Care
Insurance Carriers
Health Insurance
Medical Audit
Social Security
Population
Motivation
Public Health
Costs and Cost Analysis
Health

Keywords

  • Cancer screening
  • Health insurance
  • Japan
  • Korea
  • Screening rate

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology
  • Medicine(all)

Cite this

Why screening rates vary between Korea and Japan-Differences between two national healthcare systems. / Goto, Rei; Hamashima, Chisato; Mun, Sunghyun; Lee, Won Chul.

In: Asian Pacific Journal of Cancer Prevention, Vol. 16, No. 2, 2015, p. 395-400.

Research output: Contribution to journalShort survey

@article{fd2a9f81b6304ab8a31370da3e5141da,
title = "Why screening rates vary between Korea and Japan-Differences between two national healthcare systems",
abstract = "Both Japan and Korea provide population-based screening programs. However, screening rates are much higher in Korea than in Japan. To clarify the possible factors explaining the differences between these two countries, we analyzed the current status of the cancer screening and background healthcare systems. Populationbased cancer screening in Korea is coordinated well with social health insurance under a unified insurer system. In Japan, there are over 3,000 insurers and coordinating a comprehensive strategy for cancer screening promotion has been very difficult. The public healthcare system also has influence over cancer screening. In Korea, public healthcare does not cover a wide range of services. Almost free cancer screening and subsidization for medical cost for cancers detected in population-screening provides high incentive to participation. In Japan, on the other hand, a larger coverage of medical services, low co-payment, and a lenient medical audit enables people to have cancer screening under public health insurance as well as the broad range of cancer screening. The implementation of evidence-based cancer screening programs may be largely dependent on the background healthcare system. It is important to understand the impacts of each healthcare system as a whole and to match the characteristics of a particular health system when designing an efficient cancer screening system.",
keywords = "Cancer screening, Health insurance, Japan, Korea, Screening rate",
author = "Rei Goto and Chisato Hamashima and Sunghyun Mun and Lee, {Won Chul}",
year = "2015",
doi = "10.7314/APJCP.2015.16.2.395",
language = "English",
volume = "16",
pages = "395--400",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "2",

}

TY - JOUR

T1 - Why screening rates vary between Korea and Japan-Differences between two national healthcare systems

AU - Goto, Rei

AU - Hamashima, Chisato

AU - Mun, Sunghyun

AU - Lee, Won Chul

PY - 2015

Y1 - 2015

N2 - Both Japan and Korea provide population-based screening programs. However, screening rates are much higher in Korea than in Japan. To clarify the possible factors explaining the differences between these two countries, we analyzed the current status of the cancer screening and background healthcare systems. Populationbased cancer screening in Korea is coordinated well with social health insurance under a unified insurer system. In Japan, there are over 3,000 insurers and coordinating a comprehensive strategy for cancer screening promotion has been very difficult. The public healthcare system also has influence over cancer screening. In Korea, public healthcare does not cover a wide range of services. Almost free cancer screening and subsidization for medical cost for cancers detected in population-screening provides high incentive to participation. In Japan, on the other hand, a larger coverage of medical services, low co-payment, and a lenient medical audit enables people to have cancer screening under public health insurance as well as the broad range of cancer screening. The implementation of evidence-based cancer screening programs may be largely dependent on the background healthcare system. It is important to understand the impacts of each healthcare system as a whole and to match the characteristics of a particular health system when designing an efficient cancer screening system.

AB - Both Japan and Korea provide population-based screening programs. However, screening rates are much higher in Korea than in Japan. To clarify the possible factors explaining the differences between these two countries, we analyzed the current status of the cancer screening and background healthcare systems. Populationbased cancer screening in Korea is coordinated well with social health insurance under a unified insurer system. In Japan, there are over 3,000 insurers and coordinating a comprehensive strategy for cancer screening promotion has been very difficult. The public healthcare system also has influence over cancer screening. In Korea, public healthcare does not cover a wide range of services. Almost free cancer screening and subsidization for medical cost for cancers detected in population-screening provides high incentive to participation. In Japan, on the other hand, a larger coverage of medical services, low co-payment, and a lenient medical audit enables people to have cancer screening under public health insurance as well as the broad range of cancer screening. The implementation of evidence-based cancer screening programs may be largely dependent on the background healthcare system. It is important to understand the impacts of each healthcare system as a whole and to match the characteristics of a particular health system when designing an efficient cancer screening system.

KW - Cancer screening

KW - Health insurance

KW - Japan

KW - Korea

KW - Screening rate

UR - http://www.scopus.com/inward/record.url?scp=84925448025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925448025&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2015.16.2.395

DO - 10.7314/APJCP.2015.16.2.395

M3 - Short survey

C2 - 25684461

AN - SCOPUS:84925448025

VL - 16

SP - 395

EP - 400

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 2

ER -